Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis.
Elisa García GarreGinés Luengo GilSilvia Montoro GarcíaEnrique Gonzalez BillalabeitiaMarta Zafra PovesElena García MartinezVanessa Roldán SchillingEsther Navarro ManzanoAlejandra Ivars RubioGregory Y H LipFrancisco AyalaPublished in: Breast cancer research and treatment (2018)
Our results did not support sEMP as a marker of response to chemotherapy. However, our exploratory analysis suggests that in patients with metastatic breast cancer, the decrease of sEMP levels after chemotherapy is associated with better overall and disease free survival and might be superior to VEGFA levels as an angiogenesis-related prognostic marker.